IUPAC-Richter Prize in Medicinal Chemistry

2024 IUPAC-Richter Prize in Medicinal Chemistry - Call for Nominations

The 2024 IUPAC-Richter-Prize will be presented during the XXVIII EFMC International Symposium on Medicinal Chemistry (September 1-5, 2024) in Rome (Italy) and the recipient will also give a lecture on the subject of their research at the 38th ACS National Medicinal Chemistry Symposium (June 23-26) in Seattle, WA, United States. The prize is to be awarded to an internationally recognized scientist, preferably a medicinal chemist, whose activities or published accounts have made an outstanding contribution to the practice of medicinal chemistry or to an outstanding example of new drug discovery

Prize USD 10 000

The Prize has been established by a generous gift from the Chemical Works of Gedeon Richter, Plc. (Budapest, Hungary) to acknowledge the key role that medicinal chemistry plays toward improving human health.

Applicants should be received by NOMINATION only, with just one person needing to serve in that capacity, although a total of five (5) individuals should be listed as referees overall. The package must be submitted electronically and should contain a complete resume, a professional biography of not more than two pages, and a one-page summary of what the individual considers to be their activities, accomplishments and/or publications that have had the most significant impact upon the field of Medicinal Chemistry. The material will be forwarded confidentially to an independent selection committee appointed by the IUPAC Subcommittee on Medicinal Chemistry and Drug Development.

For further information please contact Prof. Janos Fischer, Member of the IUPAC Subcommittee on Drug Discovery and Development, by email at  .

Nomination materials should be uploaded by 15 December 2023 to IUPAC Secretariat via the following form.

Michael E. Jung awardee of the 2022 IUPAC - RICHTER PRIZE

Michael E. Jung, Head of the Department of Chemistry and Biochemistry at UCLA, has been awarded the 2022 IUPAC-Richter Prize in recognition of his research, which has afforded new drugs for the treatment of advanced prostate cancer.

The acceptance lecture will be held in New York, NY, USA (June 26-29, 2022) at the 37th ACS National Medicinal Chemistry Symposium and he will present a second lecture at the XXVII EFMC International Symposium on Medicinal Chemistry in Nice, France (Sept. 4-8, 2022).

This year marks the ninth occasion of the IUPAC-Richter Prize, which was established in 2005 by the IUPAC (International Union of Pure and Applied Chemistry) and Richter PLC. Awarded biannually, the awardee is announced by the IUPAC following nominations and the decision of an indepedent international selection committee. According to the rules of the prize, the awardee is expected to give two lectures, one in Europe and one in the United States, at international symposia on medicinal chemistry. The lecture in which the prize is awarded occurs alternatively in Europe and in the United States. The awardee receives an award of $10,000, which is sponsored by Richter PLC, and a plaque, which is presented by IUPAC.

The awardee receives $10 000, which is sponsored by Richter PLC,  and a plaque, which is presented by IUPAC.

The previous awardees were :

  • 2006 : Malcolm FG Stevens (UK)
  • 2008: Jan Heeres (Belgium)
  • 2010 : Arun Ghosh (USA)
  • 2012 : Stephen Hanessian (Canada)
  • 2014 : Helmut Buschmann (Germany)
  • 2016 : Michael Sofia (USA)
  • 2018 : Peter Grootenhuis (USA)
  • 2020: John Macor (USA)